082 smoking and plaque inflammation
-
Upload
shape-society -
Category
Health & Medicine
-
view
15 -
download
0
Transcript of 082 smoking and plaque inflammation
Editorial Slides VP Watch, February 19, 2003, Volume 3, Issue 6
What Is The Link Between Smoking And Plaque Inflammation?
– Furie et al Habitual use of smokeless tobacco leads to accumulation of inflammatory leukocytes at the site of placement, which may contribute to tissue damage. 2
– Their observations suggested that smokeless tobacco may induce inflammatory changes in vivo by activating endothelium in a manner that promotes recruitment of leukocytes. 2
–Tottie et al showed that nicotine is chemotactic for neutrophil and enhances neutrophil responsiveness to chemotactic peptides. 3
–Klapproth et al showed nicotine and ligands of nicotine receptors release GM-CSF from epithelial cells.4
– Bobryshev and Lord have reported “Vascular Dendritic Cells” in areas prone to atherosclerotic plaque formation. 5
- These dendritic cells may play a key role in the initiation of atherosclerosis. 6
–As featured in VP Watch of the Week, Aicher et al1 investigated the effect of nicotine on the dendritic cell- mediated adaptive immunity.
–In the following slides, the investigators showed various effectd of nicotine on expression of nicotinic acetylcholine receptor in human dendritic cells.
7-nicotinic acetylcholine receptor (nAChR) 7-nicotinic acetylcholine receptor (nAChR) expression on DCs is up-regulated after expression on DCs is up-regulated after
nicotine stimulationnicotine stimulation
Control
7-nAChR expression 7-nAChR expression NAChR expression in DC cells was increased by nicotine in a NAChR expression in DC cells was increased by nicotine in a
dose-dependent manner.dose-dependent manner.
Nicotine: 10-8 M
Nicotine: 10-7 M
Provided by Dr. Stefanie Dimmeler
Nicotine induces a dose-dependent increase in the expression of the co-stimulatory molecule CD86
PBS 10-8 10-7 10-6 10-5 10-4 10-7 10-4 M
Cha
nge
in C
D86
exp
ress
ion
(%)
Mecamylamine(MEC; 10-7 M)
*
*
*
* *
* P<0.01 versus PBS
Nicotine
250
200
150
100
50
CD86PBS
nicotine
isotype
MECMEC
Ca++Na+
K+
AChAChNicotineNicotine
--nAChR nAChR ++
Provided by Dr. Stefanie Dimmeler
Dose-dependent cytotoxicity of nicotine
Perc
enta
ge o
f dea
d D
Cs
* P<0.01 versus PBS *
*
*
0
20
40
60
80
100
120
PBS 10-7 10-6 10-5 10-4 10-3 10-2
Nicotine
M
Provided by Dr. Stefanie Dimmeler
Nicotine enhances expression of surface molecules involved in inflammation
Cha
nge
in e
xpre
ssio
n (%
of c
ontr
ol)
isotypePBS nicotine
PBS
nicotineisotype
PBS nicotineisotype
PBS nicotine
isotype
50
100
150
200
250
CD
11a
CD
11a
CD
18C
D18
CD
54C
D54
CD
40C
D40
CD
83C
D83
CD
86C
D86
HLA
-DR
HLA
-DR
CD86 CD54
MHC class II CD40
Provided by Dr. Stefanie Dimmeler
Nicotine-induced IL-12 p40 production in DCs is mediated through nACh receptors
* P<0.01 versus PBS
PBS
IL-1
2 (p
g/m
l)
200
100
0Nicotine Nicotine
+ BTX
Nicotine +
MEC
*
BTX: -Bungarotoxin (7-nAChR antagonist)
MEC: Mecamylamine (unselective nAChR
antagonist)
MECMEC
Ca++Na+
K+
AChAChNicotineNicotine
--nAChR nAChR ++BTX
Both nicotine antagonists prevented nicotine-induced IL-12 P40 production Provided by Dr. Stefanie Dimmeler
Nicotine-prestimulated dendritic cells (DCs) and monocytes (MCs) induce allogeneic T cell activation
IL-2
(pg/
ml)
nicotine
DC / T cell ratio (1:10)
LPS
DC / T cell ratio (1:50)
200
100
0
300
PBS
**
* *
* P<0.01 versus PBS
0
200
100
300
*
*
**
MC / T cell ratio (1:10)
MC / T cell ratio (1:50)
* P<0.01 versus PBS
IL-2
(pg/
ml)
nicotineLPS
PBS nicotine
LPS
PBS nicotine
LPS
PBS
Provided by Dr. Stefanie Dimmeler
CSF
E
CD4
MCs
control
nicotine
DCs
Proliferation of allogeneic CSFE-labeled CD4+ T cells in mixed lymphocyte reactions with nicotine-stimulated
DCs or MCs as stimulator cells
CD4-allophycocyanin
7.2%
24.1%
5.2%
10.7%
Loss of incorporated CSFE labeling was increased by nicotine, indicating its enhancing effect on proliferation of T-lymphocytes. Provided by Dr. Stefanie Dimmeler
IL-2
(pg/
ml)
0
20
40
60
80
100
120
140
PBS 0.1 1.0
PBS Nicotine
*
*
*
OVA (µg/ml)
* P<0.01 versus PBS
Nicotine-preactivated DCs stimulate OVA-TCR-transgenic T cells in OVA-antigen specific assays
OVA: ovalbumine peptide 323-339
OVA-TCR transgenic mice
OVA
OVA-TCR
Provided by Dr. Stefanie Dimmeler
Nicotine-preactivated DCs increase expression of CD40 ligand (CD40L) on T cells
0
10
20
30
40
PBS nicotine
CD
40 L
+ T c
ells
(%)
*
* P<0.01 versus PBS
Provided by Dr. Stefanie Dimmeler
Nicotine activates MAPK and Akt pathways
phospho p38
β-tubulinA
phospho Erk1/2
β-tubulinB
0 5 15 30 60 120 min
phospho Akt
β-tubulinC
These studies demonstrate that the effects of nicotine are mediated, at least in part, by phosphorylation of Akt and MAPK
Provided by Dr. Stefanie Dimmeler
isotype
PBS
nicotine + PD98059
nicotine
nicotine + SB203580
nicotine + LY294002
CD86
LY294002: PI3-K inhibitor
PD98059: MEK 1/2 inhibitor (ERK-pathway)SB203580: p38 MAPK inhibitor
Nicotine-induced up-regulation of CD86 is strongly dependent on MAPK and phosphatidylinositoI-3 (PI3) kinase
These studies demonstrate that the effects of nicotine are mediated, at least in part, by phosphorylation of Akt and MAPK
Provided by Dr. Stefanie Dimmeler
control nicotine
B
Homing of CSFE-labeled DCs to atherosclerotic plaques in nicotine-treated hypercholesterolemic mice
Nicotine induced recruitment of dendritic cells into the atherosclerotic plaque in vivo Provided by Dr. Stefanie Dimmeler
Summary Nicotine enhances adaptive immunity andmay contribute to plaque destabilization
NicotineNicotine
Adaptive Adaptive immunity immunity
Plaque Plaque destabilizationdestabilization
Provided by Dr. Stefanie Dimmeler
Conclusion:Nicotine has a direct proinflammatory effect through enhancement of cell-mediated adaptive immunity.
Conclusion: Nicotine enhances the
recruitment of dendritic cells to atherosclerotic plaques which can result in increasing recruitment of monocytes / macrophages to plaque.
Questions:The role of smoking in cardiovascular disease is
more related to the contribution of nicotine:
1- to endothelial injury and initiation of atherosclerotic plaque
2- to progression of plaques that already exist
3- to thrombotic complications of plaquescontinue next page
Questions:
4- to increased thrombogenesity of blood
5- to increased arrhythmogenesity of myocardium
6- to increased respiratory infections and total infectious burden